EP1563064A2 - Subtilasevarianten - Google Patents

Subtilasevarianten

Info

Publication number
EP1563064A2
EP1563064A2 EP03769258A EP03769258A EP1563064A2 EP 1563064 A2 EP1563064 A2 EP 1563064A2 EP 03769258 A EP03769258 A EP 03769258A EP 03769258 A EP03769258 A EP 03769258A EP 1563064 A2 EP1563064 A2 EP 1563064A2
Authority
EP
European Patent Office
Prior art keywords
variant
subtilase
variants
s99sd
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03769258A
Other languages
English (en)
French (fr)
Inventor
Henriette Dragborg
Peter Kamp Hansen
Mads Eskelund BJÖRNVAD
Mads NÖRREGAARD-MADSEN
Mikael Mikkelsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novozymes AS
Original Assignee
Novozymes AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes AS filed Critical Novozymes AS
Priority to EP09172028.4A priority Critical patent/EP2138574B1/de
Priority to EP20100180046 priority patent/EP2284258A3/de
Priority to EP10183162.6A priority patent/EP2399992A3/de
Publication of EP1563064A2 publication Critical patent/EP1563064A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Definitions

  • the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: Wash performance, thermal stability, storage stability or catalytic activity.
  • the variants of the invention are suitable for use in e.g. cleaning or detergent compositions, such as laundry detergent compositions and dish wash compositions, including automatic dish wash compositions.
  • the present invention also relates to isolated DNA sequences encoding the variants, expression vectors, host cells, and methods for producing and using the variants of the invention. Further, the present invention relates to cleaning and detergent compositions comprising the variants of the invention.
  • Enzymes used in such formulations comprise proteases, lipases, amyiases, cellulases, as well as other enzymes, or mixtures thereof. Commercially the most important enzymes are proteases.
  • proteases protein engineered variants of naturally occurring wild type proteases, e.g. Durazym ® , Relase ® , Alcalase ® , Savinase ® , Primase ® , Duralase ® , Esperase ® , Ovozyme ® and Kannase ® (Novozymes A/S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, FN3TM and FN4TM (Genencor International, Inc.). Further, a number of protease variants are described in the art. A thorough list of prior art protease variants is given in WO 99/27082.
  • an object of the present invention is to provide improved subtilase variants for such purposes.
  • the present invention relates to a subtilase variant comprising at least a) an insertion, substitution or deletion of one of the amino acid residues K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S,T in one or more of the positions
  • N173D A174V; M175L,I,V,A,S,T; N183D; N184D.S; N185S.D; R186L,C,H; S188G; S190A;
  • modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P, ,F,W,Y,GAS and T.
  • the present invention relates to a subtilase variant comprising a) the combination of one or more of the modifications X62D,XD,XE,XG,DE
  • the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table I below:
  • subtilase variants of the inventions having one or more of the alterations:
  • each position corresponds to a position of the amino acid sequence of subtilisin B PN', shown in Figure 1 and SEQ ID NO: 1.
  • the present invention relates to an isolated polynucleotide encoding a subtilase variant of the invention.
  • the present invention relates to an expression vector comprising the isolated polynucleotide of the invention.
  • the present invention relates to a microbial host cell transformed with the expression vector of the invention.
  • the present invention relates to a method for producing a subtilase variant according to the invention, wherein a host according to the invention is cultured under conditions conducive to the expression and secretion of the variant, and the variant is recovered.
  • the present invention relates to a cleaning or detergent composition, preferably a laundry or dish wash composition, comprising the variant of the invention.
  • the present invention relates to a subtilase variant comprising at least one of the alterations disclosed in Table II below:
  • subtilase variants of the inventions having one or more of the alterations:
  • each position corresponds to a position of the amino acid sequence of subtilisin B PN', shown in Figure 1 and SEQ ID NO: 1.
  • the present invention relates to a subtilase variant comprising one of the alterations N252D and N252M.
  • the present invention relates to a subtilase variant comprising one or more of the alterations M119L, I, V, A, S; M175L, I, V, A, S and M222L, I, V, A, S in combination with the subtilase variants listed in tables I and II above.
  • Fig. 1 shows an alignment between subtilisin BPN'(a) (BASBPN) and subtilisin 309 (b) (BLSAVI). This alignment is in this patent application used as a reference for numbering the residues.
  • a frame of reference is first defined by aligning the isolated or parent enzyme with subtilisin BPN' (BASBPN).
  • Another method is to use known recognized alignments between subtilases, such as the alignment indicated in WO 91/00345. In most cases the differences will not be of any importance.
  • subtilisin 309 SEQ ID NO.2
  • subtilisin 309 SEQ ID NO.2
  • Enzymes cleaving the amide linkages in protein substrates are classified as proteases, or (interchangeably) peptidases (see Walsh, 1979, Enzymatic Reaction Mechanisms. W.H. Freeman and Company, San Francisco, Chapter 3).
  • subtilase BPN subtilase BPN' (BASBPN) sequence.
  • BPN' sequence see Fig. 1 , SEQ ID NO:1 or Siezen et al., Protein Engng. 4 (1991) 719-737.
  • a serine protease is an enzyme which catalyzes the hydrolysis of peptide bonds, and in which there is an essential serine residue at the active site (White, Handler and Smith, 1973 "Principles of Biochemistry," Fifth Edition, McGraw-Hill Book Company, NY, pp. 271-272).
  • the bacterial serine proteases have molecular weights in the 20,000 to 45,000 Dalton range. They are inhibited by diisopropylfluorophosphate. They hydrolyze simple terminal esters and are similar in activity to eukaryotic chymotrypsin, also a serine protease.
  • alkaline protease covering a sub-group, reflects the high pH optimum of some of the serine proteases, from pH 9.0 to 11.0 (for review, see Priest (1977) Bacteriological Rev. 41 711-753).
  • subtilases A sub-group of the serine proteases tentatively designated subtilases has been proposed by Siezen et al., Protein Engng. 4 (1991) 719-737 and Siezen et al. Protein Science 6 (1997) 501-523. They are defined by homology analysis of more than 170 amino acid sequences of serine proteases previously referred to as subtilisin-like proteases. A subtilisin was previously often defined as a serine protease produced by Gram-positive bacteria or fungi, and according to Siezen et al. now is a subgroup of the subtilases. A wide variety of subtilases have been identified, and the amino acid sequence of a number of subtilases has been determined. For a more detailed description of such subtilases and their amino acid sequences reference is made to Siezen et al. (1997).
  • subtilisin 168 subtilisin 168
  • subtilisin BPN subtilisin BPN
  • subtilisin Carlsberg ALCALASE ®
  • NOVOZYMES A/S subtilisin Carlsberg
  • subtilisin DY subtilisin DY
  • subtilases I-S2 or high alkaline subtilisins
  • Sub-group I-S2 proteases are described as highly alkaline subtilisins and comprises enzymes such as subtilisin PB92 (BAALKP) (MAXACAL ® , Genencor International Inc.), subtilisin 309 (SAVINASE ® , NOVOZYMES A/S), subtilisin 147 (BLS147) (ESPERASE ® , NOVOZYMES A S), and alkaline elastase YaB (BSEYAB).
  • SAVINASE® is marketed by NOVOZYMES A/S. It is subtilisin 309 from B. Lentus and differs from BAALKP only in one position (N87S). SAVINASE® has the amino acid sequence designated b) in Fig. 1 and in SEQ ID NO:2.
  • parent subtilase describes a subtilase defined according to Siezen et al. (1991 and 1997). For further details see description of "Subtilases” above.
  • a parent subtilase may also be a subtilase isolated from a natural source, wherein subsequent modifications have been made while retaining the characteristic of a subtilase.
  • a parent subtilase may be a subtilase which has been prepared by the DNA shuffling technique, such as described by J.E. Ness et al., Nature Biotechnology, 17, 893-896 (1999). Alternatively the term "parent subtilase” may be termed "wild type subtilase".
  • Modification(s) of a subtilase variant The term "modification(s)" used herein is defined to include chemical modification of a subtilase as well as genetic manipulation of the DNA encoding a subtilase.
  • the modification(s) can be replacement(s) of the amino acid side chain(s), substitution(s), deletion(s) and/or insertions in or at the amino acid(s) of interest.
  • subtilase variant or mutated subtilase means a subtilase that has been produced by an organism which is expressing a mutant gene derived from a parent microorganism which possessed an original or parent gene and which produced a corresponding parent enzyme, the parent gene having been mutated in order to produce the mutant gene from which said mutated subtilase protease is produced when expressed in a suitable host.
  • GCG package version 9.1 can be applied (infra) using the same settings.
  • the output from the routine is besides the amino acid alignment the calculation of the "Percent Identity" between the two sequences.
  • isolated when applied to a polynucleotide, denotes that the polynucleotide has been removed from its natural genetic milieu and is thus free of other extraneous or unwanted coding sequences, and is in a form suitable for use within genetically engineered protein production systems.
  • isolated molecules are those that are separated from their natural environment and include cDNA and genomic clones.
  • Isolated DNA molecules of the present invention are free of other genes with which they are ordinarily associated, but may include naturally occurring 5' and 3" untranslated regions such as promoters and terminators. The identification of associated regions will be evident to one of ordinary skill in the art (see for example, Dynan and Tijan, Nature 316:774-78, 1985).
  • the term "an isolated polynucleotide” may alternatively be termed "a cloned polynucleotide”.
  • the term “isolated” indicates that the protein has been removed from its native environment.
  • the isolated protein is substantially free of other proteins, particularly other homologous proteins (i.e. "homologous impurities” (see below)).
  • An isolated protein is more than 10% pure, preferably more than 20% pure, more preferably more than 30% pure, as determined by SDS-PAGE. Further it is preferred to provide the protein in a highly purified form, i.e., more than 40% pure, more than 60% pure, more than
  • isolated protein may alternatively be termed “purified protein”.
  • homologous impurities means any impurity (e.g. another polypeptide than the subtilase of the invention), which originate from the homologous cell where the subtilase of the invention is originally obtained from.
  • the term "obtained from” as used herein in connection with a specific microbial source means that the polynucleotide and/or subtilase produced by the specific source, or by a cell in which a gene from the source has been inserted.
  • substrate used in connection with a substrate for a protease should be interpreted in its broadest form as comprising a compound containing at least one peptide (amide) bond susceptible to hydrolysis by a subtilisin protease.
  • product used in connection with a product derived from a protease enzymatic reaction should, in the context of the present invention, be interpreted to include the products of a hydrolysis reaction involving a subtilase protease.
  • a product may be the substrate in a subsequent hydrolysis reaction.
  • wash performance is used as an enzyme's ability to remove proteinaceous or organic stains present on the object to be cleaned during e.g. wash or hard surface cleaning. See also the wash performance test in Example 3 herein.
  • Fig. 1 shows an alignment between subtilisin BPN' (a) and Savinase®(b) using the GAP routine mentioned above.
  • the present invention relates to novel subtilase variants exhibiting alterations relative to the parent subtilase in one or more properties including: Wash performance, thermal stability, storage stability or catalytic activity.
  • variants which are contemplated as being part of the invention are such variants where, when compared to the wild-type subtilase, one or more amino acid residues has been substituted, deleted or inserted, said variants comprising at least
  • modification(s) comprise(s): deletion, insertion and/or substitution of an amino acid residue selected from the group consisting of K,H,R,E,D,Q,N,C,V,L,I,P,M,F,W,Y,G,A,S and T.
  • variants of the present invention comprises at least one or more of the alterations indicated in Table I and II, wherein
  • a subtilase variant of the first aspect of the invention may be a parent or wild-type subtilase identified and isolated from nature. Such a parent wild-type subtilase may be specifically screened for by standard techniques known in the art.
  • One preferred way of doing this may be by specifically PCR amplify conserved DNA regions of interest from subtilases from numerous different microorganism, preferably different Bacillus strains.
  • Subtilases are a group of conserved enzymes, in the sense that their DNA and amino acid sequences are homologous. Accordingly it is possible to construct relatively specific primers flanking the polynucleotide sequences of interest.
  • subtilase variants of the invention is predominantly a variant of a parent subtilase.
  • a subtilase variant suitable for the uses described herein may be constructed by standard techniques known in the art such as by site-directed/random mutagenesis or by DNA shuffling of different subtilase sequences. See the "Material and Methods" section and Example 1 herein (vide infra) for further details.
  • variants described herein may comprise one or more further modifications, in particular one or more further substitutions or insertions.
  • the variants described herein may encompass mutation at more than just one position.
  • the variant according to the invention may contain mutations at one position, two positions, three positions or more than three positions, such as four to eight positions.
  • the parent subtilase belongs to the subgroups I-S1 or I-S2, especially subgroup I-S2, both for enzymes from nature or from the artificial creation of diversity, and for designing and producing variants from a parent subtilase.
  • subtilase In relation to variants from subgroup I-S1 , it is preferred to select a parent subtilase from the group consisting of BSS168 (BSSAS, BSAPRJ, BSAPRN, BMSAMP), BASBPN, BSSDY, BLSCAR (BLKERA, BLSCA1 , BLSCA2, BLSCA3), BSSPRC, and BSSPRD, or functional variants thereof having retained the characteristic of sub-group I-S1.
  • subtilase In relation to variants from subgroup I-S2 it is preferred to select a parent subtilase from the group consisting of BSAPRQ, BLS147 (BSAPRM, BAH 101 ), BLSAVI (BSKSMK, BAALKP, BLSUBL), BYSYAB, BAPB92, TVTHER, and BSAPRS, or functional variants thereof having retained the characteristic of sub-group I-S2.
  • the parent subtilase is BLSAVI (Savinase®, NOVOZYMES A/S), and a preferred subtilase variant of the invention is accordingly a variant of Savinase®.
  • the present invention also encompasses any of the a bove m entioned s ubtilase variants i n combination with any other modification to the amino acid sequence thereof. Especially com- binations with other modifications known in the art to provide improved properties to the enzyme are envisaged.
  • the art describes a number of subtilase variants with different improved properties and a number of those are mentioned in the "Background of the invention" section herein (vide supra). Those references are disclosed here as references to identify a subtilase variant, which advantageously can be combined with a subtilase variant described herein.
  • subtilase variant described herein may advantageously be combined with one or more modification(s) in any of the positions:
  • a particular interesting variant is a variant, which, in addition to modifications according to the invention, contains the following substitutions:
  • subtilase variants of the main aspect(s) of the invention are preferably combined with one or more modification(s) in any of the positions 129, 131 and 194, preferably as 129K, 131H and 194P modifications, and most preferably as P129K, P131H and A194P modifications. Any of those modification(s) are expected to provide a higher expression level of the subtilase variant in the production thereof.
  • the wash performance of a selected variant of the invention may be tested in the wash performance test disclosed in Example 3 herein.
  • the wash performance test may be employed to assess the ability of a variant, when incorporated in a standard or commercial detergent composition, to remove proteinaceous stains from a standard textile as compared to a reference system, namely the parent subtilase or a similar subtilase exhibiting an even better wash performance (incorporated in the same detergent system and tested under identical conditions).
  • the enzyme variants of the present application were tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined rapidly. Using this test, the wash performance of a selected variant can be initially investigated, the rationale being that if a selected variant does not show a significant improvement in the test compared to the parent subtilase, it is normally not necessary to carry out further test experiments.
  • AMSA Automatic Mechanical Stress Assay
  • variants which are particularly interesting for the purposes described herein are such variants which, when tested in a commercial detergent composition such as a US type detergent, an Asian type, a European type or a Latin American type detergent as described in the wash performance test (Example 3), shows an improved wash performance as compared to the parent subtilase tested under identical conditions.
  • a commercial detergent composition such as a US type detergent, an Asian type, a European type or a Latin American type detergent as described in the wash performance test (Example 3)
  • the improvement in the wash performance may be quantified by calculating the so-called intensity value (Int) defined in Example 3, herein.
  • the variant of the invention when tested in the wash performance test has a Performance Score (S) of at least 1 , preferably a
  • S (1) variant performs better than the reference at one or two concentrations.
  • the variant of the invention fulfils the above criteria on at least the stated lowest level, more preferably at the stated highest level.
  • subtilase genes Many methods for cloning a subtilase and for introducing substitutions, deletions or insertions into genes (e.g. subtilase genes) are well known in the art.
  • subtilase variant of the invention In general standard procedures for cloning of genes and introducing mutations (random and/or site directed) into said genes may be used in order to obtain a subtilase variant of the invention.
  • suitable techniques reference is made to Example 1 herein (vide infra) and (Sambrook et al. (1989) Molecular cloning: A laboratory manual, Cold Spring Harbor lab., Cold Spring Harbor, NY; Ausubel, F. M. et al. (eds.) "Current protocols in Molecular Biology”. John Wiley and Sons, 1995; Harwood, C. R., and Cutting, S. M. (eds.) "Molecular Biological Methods for Bacillus”. John Wiley and Sons, 1990), and WO 96/34946.
  • subtilase variant may be constructed by standard techniques for artificial creation of diversity, such as by DNA shuffling of different subtilase genes (WO 95/22625; Stemmer WPC, Nature 370:389-91 (1994)). DNA shuffling of e.g. the gene encoding Savinase® with one or more partial subtilase sequences identified in nature, will after subsequent screening for improved wash performance variants, provide subtilase variants suitable for the purposes described herein.
  • a recombinant expression vector comprising a DNA construct encoding the e nzyme o f t he invention may be any vector that may conveniently be subjected to recombinant D NA p rocedures.
  • the vector may be an autonomously replicating vector, i.e. a vector that exists as an extra- chromosomal entity, the replication of which is independent of chromosomal replication, e.g. a plasmid.
  • the vector may be one that on introduction into a host cell is integrated into the host cell genome in part or in its entirety and replicated together with the chromosome(s) into which it has been integrated.
  • the vector is preferably an expression vector in which the DNA sequence encoding the enzyme of the invention is operably linked to additional segments required for transcription of the DNA.
  • the expression vector is derived from plasmid or viral DNA, or may contain elements of both.
  • operably linked indicates that the segments are arranged so that they function in concert for their intended purposes, e.g. transcription initiates in a promoter and proceeds through the DNA sequence coding for the enzyme.
  • the promoter may be any DNA sequence that shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • suitable promoters for use in bacterial host cells include the promoter of the Bacillus stearothermophilus maltogenic amylase gene, the Bacillus licheniformis alpha- amylase gene, the Bacillus amyloliquefaciens alpha-amylase gene, the Bacillus subtilis alkaline protease gene, or the Bacillus pumilus xylosidase gene, or the phage Lambda P R or PL promoters or the E. coli lac, trp or tac promoters.
  • the DNA sequence encoding the enzyme of the invention may also, if necessary, be operably connected to a suitable terminator.
  • the recombinant vector of the invention may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
  • the vector may also comprise a selectable marker, e.g. a gene the product of which complements a defect in the host cell, or a gene encoding resistance to e.g. antibiotics like kanamycin, chloramphenicol, erythromycin, tetracycline, spectinomycine, or the like, or resistance to heavy metals or herbicides.
  • a secretory signal sequence (also known as a leader sequence, prepro sequence or pre sequence) may be provided in the recombinant vector.
  • the secretory signal sequence is joined to the DNA sequence encoding the enzyme in the correct reading frame.
  • Secretory signal s equences a re commonly positioned 5' to the DNA sequence encoding the enzyme.
  • the secretory signal sequence may be that normally associated with the enzyme or may be from a gene encoding another secreted protein.
  • the DNA sequence encoding the present enzyme introduced into the host cell may be either homologous or heterologous to the host in question. If homologous to the host cell, i.e. produced by the host cell in nature, it will typically be operably connected to another promoter sequence or, if applicable, another secretory signal sequence and/or terminator sequence than in its natural environment.
  • the term "homologous” is intended to include a DNA sequence encoding an enzyme native to the host organism in question.
  • heterologous is intended to include a DNA sequence not expressed by the host cell in nature. Thus, the DNA sequence m ay b e f rom a nother o rganism, o r it may b e a synthetic sequence.
  • the host cell into which the DNA construct or the recombinant vector of the invention is introduced may be any cell that is capable of producing the present enzyme and includes bacteria, yeast, fungi and higher eukaryotic cells including plants.
  • Examples of bacterial host cells which, on cultivation, are capable of producing the enzyme of the invention are gram-positive bacteria such as strains of Bacillus, such as strains of B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus, B. megaterium or ⁇ . thuringiensis, or strains of Streptomyces, such as S. lividans or S. murinus, or gram-negative bacteria such as Escherichia coli.
  • Bacillus such as strains of B. subtilis, B. licheniformis, B. lentus, B. brevis, B. stearothermophilus, B. alkalophilus, B. amyloliquefaciens, B. coagulans, B. circulans, B. lautus, B. megaterium or
  • the transformation of the bacteria may be effected by protoplast transformation, electroporation, conjugation, or by using competent cells in a manner known per se (cf. Sambrook et al., supra).
  • the enzyme When expressing the enzyme in bacteria such as E. coli, the enzyme may be retained in the cytoplasm, typically as insoluble granules (known as inclusion bodies), or may be directed to the periplasmic space by a bacterial secretion sequence. In the former case, the cells a re lysed and the granules are recovered and denatured after which the enzyme is refolded by diluting the denaturing agent. In the latter case, the enzyme may be recovered from the periplasmic space by disrupting the cells, e.g. by sonication or osmotic shock, to release the contents of the periplasmic space and recovering the enzyme.
  • the enzyme When expressing the enzyme in gram-positive bacteria such as Bacillus or Streptomyces strains, the enzyme may be retained in the cytoplasm, or may be directed to the extracellular medium by a bacterial secretion sequence. In the latter case, the enzyme may be recovered from the medium as described below.
  • the present invention provides a method of producing an isolated enzyme according to the invention, wherein a suitable host cell, which has been transformed with a DNA sequence encoding the enzyme, is cultured under conditions permitting the production of the enzyme, and the resulting enzyme is recovered from the culture.
  • the medium used to culture the transformed host cells may be any conventional medium suitable for growing the host cells in question.
  • the expressed subtilase may conveniently be secreted into the culture medium and may be recovered there-from by well-known procedures including separating the cells from the medium by centrifugation or filtration, precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • the enzyme of the invention may be added to and thus become a component of a detergent composition.
  • cleaning and detergent compositions are well described in the art and reference is made to WO 96/34946; WO 97/07202; WO 95/30011 for further description of suitable cleaning and detergent compositions.
  • the detergent composition of the invention may for example be formulated as a hand or machine laundry detergent composition including a laundry additive composition suitable for pre-treatment of stained fabrics and a rinse added fabric softener composition, or be formulated as a detergent composition for use in general h ousehold h ard s urface cleaning operations, or be formulated for hand or machine dishwashing operations.
  • the invention provides a detergent additive comprising the enzyme of the invention.
  • the detergent additive as well as the detergent composition may comprise one or more other enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidase, e.g., a laccase, and/or a peroxidase.
  • enzymes such as a protease, a lipase, a cutinase, an amylase, a carbohydrase, a cellulase, a pectinase, a mannanase, an arabinase, a galactanase, a xylanase, an oxidas
  • the properties of the chosen enzyme(s) should be compatible with the selected detergent, (i.e. pH-optimum, compatibility with other enzymatic and non-enzymatic ingredients, etc.), and the enzyme(s) should be present in effective amounts.
  • proteases include those of animal, vegetable or microbial origin. Microbial origin is preferred. Chemically modified or protein engineered mutants are included.
  • the protease may be a serine protease or a metallo protease, preferably an alkaline microbial protease or a trypsin-like protease.
  • alkaline proteases are subtilisins, especially those derived from Bacillus, e.g., subtilisin Novo, subtilisin Carlsberg, subtilisin 309, subtilisin 147 a nd s ubtilisin 168 (described in WO 89/06279).
  • trypsin-like proteases are trypsin (e.g. of porcine or bovine origin) and the Fusarium protease described in WO 89/06270 and WO 94/25583.
  • useful proteases are the variants described in WO 92/19729, WO 98/20115, WO 98/20116, and WO 98/34946, especially the variants with substitutions in one or more of the following positions: 27, 36, 57, 76, 87, 97, 101 , 104, 120, 123, 167, 170, 194, 206, 218, 222, 224, 235 and 274.
  • Preferred commercially available protease enzymes include Durazym ® , Relase ® , Alcalase ® , Savinase ® , Primase ® , Duralase ® , Esperase ® , Ovozyme ® and Kannase ® (Novozymes A S), MaxataseTM, MaxacalTM, MaxapemTM, ProperaseTM, PurafectTM, Purafect OxPTM, FN2TM, FN3TM and FN4TM (Genencor International, Inc.).
  • Lipases S Amble I ipases i nclude t hose o f b acterial o r f ungal o rigin. C hemically m odified or protein engineered mutants are included. Examples of useful lipases include lipases from Humicola (synonym Thermomyces), e.g. from H. lanuginosa (T. lanuginosus) as described in EP 258 068 and EP 305 216 or from H. insolens as described in WO 96/13580, a Pseudomonas lipase, e.g. from P. alcaligenes or P. pseudoalcaligenes (EP 218 272), P.
  • Humicola semomyces
  • H. lanuginosa T. lanuginosus
  • Pseudomonas lipase e.g. from P. alcaligenes or P. pseudoalcaligenes (EP
  • cepacia EP 331 376
  • P. stutzeri GB 1 ,372,034
  • P. fluorescens Pseudomonas sp. strain SD 705 (WO 95/06720 and WO 96/27002)
  • P. wisconsinensis WO 96/12012
  • Bacillus lipase e.g. from B. subtilis (Dartois et al. (1993), Biochemica et Biophysica Acta, 1131 , 253-360), B. stearothermophilus (JP 64/744992) or ⁇ . pumilus (WO 91/16422).
  • lipase variants such as those described in WO 92/05249, WO 94/01541 , EP 407 225, EP 260 105, WO 95/35381 , WO 96/00292, WO 95/30744, WO 94/25578, WO 95/14783, WO 95/22615, WO 97/04079 and WO 97/07202.
  • Lipex ® Lipex ®
  • Lipolase ® Lipolase Ultra ®
  • Amyiases include those of bacterial or fungal origin.
  • Amyiases include, for example, ⁇ -amylases obtained from Bacillus, e.g. a special strain of B. licheniformis, described in more detail in GB 1 ,296,839.
  • amyiases examples include the variants described in WO 94/02597, WO 94/18314, WO 96/23873, and WO 97/43424, especially the variants with substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 181 , 188, 190, 197, 202, 208,
  • amyiases are Duramyl ® , Termamyl ® , Fungamyl ® and BAN ®
  • Suitable cellulases include those of bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, e.g. the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila and Fusarium oxysporum disclosed in US 4,435,307, US 5,648,263, US 5,691 ,178, US 5,776,757 and WO 89/09259. Especially suitable cellulases are the alkaline or neutral cellulases having colour care benefits.
  • cellulases examples include cellulases described in EP 0 495 257, EP 0 531 372, WO 96/11262, WO 96/29397, WO 98/08940.
  • cellulase variants such as those described in WO 94/07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95/24471 , WO 98/12307 and PCT/DK98/00299.
  • cellulases include Celluzyme ® , and Carezyme ® (Novozymes A/S), ClazinaseTM, and Puradax HATM (Genencor International Inc.), and KAC-500(B)TM (Kao Corporation).
  • Peroxidases/Oxidases include those of plant, bacterial or fungal origin. Chemically modified or protein engineered mutants are included. Examples of useful peroxidases include peroxidases from Coprinus, e.g. from C. cinereus, and variants thereof as those described in WO 93/24618, WO 95/10602, and WO 98/15257. Commercially available peroxidases include Guardzyme ® (Novozymes A/S).
  • the detergent enzyme(s) may be included in a detergent composition by adding separate additives containing one or more enzymes, or by adding a combined additive comprising all of these enzymes.
  • a detergent additive of the invention i.e. a separate additive or a combined additive, can be formulated e.g. as a granulate, a liquid, a slurry, etc.
  • Preferred detergent additive formulations are granulates, in particular non-dusting granulates, liquids, in particular stabilized liquids, or slurries.
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661 ,452 and may optionally be coated by methods known in the art.
  • waxy coating materials are poly(ethylene oxide) products (polyethyleneglycol, PEG) with mean molar weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • the detergent composition of the invention may be in any convenient form, e.g., a bar, a tablet, a powder, a granule, a paste or a liquid.
  • a liquid detergent may be aqueous, typically containing up to 70 % water and 0-30 % organic solvent, or non-aqueous.
  • the detergent composition comprises one or more surfactants, which may be non-ionic including semi-polar and/or anionic and/or cationic and/or zwitterionic.
  • the surfactants are typically present at a level of from 0.1% to 60% by weight.
  • the detergent When included therein the detergent will usually contain from about 1 % to about 40% of an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, a lkyl s ulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • an anionic surfactant such as linear alkylbenzenesulfonate, alpha-olefinsulfonate, a lkyl s ulfate (fatty alcohol sulfate), alcohol ethoxysulfate, secondary alkanesulfonate, alpha-sulfo fatty acid methyl ester, alkyl- or alkenylsuccinic acid or soap.
  • the detergent When included therein the detergent will usually contain from about 0.2% to about 40% of a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanol- amide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides").
  • a non-ionic surfactant such as alcohol ethoxylate, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamineoxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanol- amide, polyhydroxy alkyl fatty acid amide, or N-acyl N-alkyl derivatives of glucosamine (“glucamides”).
  • glucamides N-acyl N-alkyl derivatives of glucosamine
  • the detergent may contain 0-65 % of a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylene- diaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenyl-succinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • a detergent builder or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, carbonate, citrate, nitrilotriacetic acid, ethylene- diaminetetraacetic acid, diethylenetriaminepentaacetic acid, alkyl- or alkenyl-succinic acid, soluble silicates or layered silicates (e.g. SKS-6 from Hoechst).
  • the detergent may comprise one or more polymers.
  • examples are carboxymethyl-cellulose, poly(vinylpyrrolidone), poly (ethylene glycol), poly(vinyl alcohol), poly(vinyl-pyridine-N-oxide), poly(vinylimidazole), polycarboxylates such as poly-acrylates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent may contain a bleaching system which may comprise a H 2 O 2 source such as perborate or percarbonate which may be combined with a p eracid-forming b leach a ctivator such as tetraacetylethylenediamine or nonanoyloxybenzenesulfonate.
  • a bleaching system may comprise peroxyacids of e.g. the amide, imide, or sulfone type.
  • the detergent may also contain other conventional detergent ingredients such as e.g. fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • fabric conditioners including clays, foam boosters, suds suppressors, anti-corrosion agents, soil- suspending agents, anti-soil redeposition agents, dyes, bactericides, optical brighteners, hydrotropes, tarnish inhibitors, or perfumes.
  • Detergent Examples 1 and 2 provide ranges for the composition of a typical Latin American detergent and a typical European powder detergent respectively.
  • Detergent Example 1 Typical Latin American detergent composition.
  • the enzyme(s) of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g., a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid, and the composition may be formulated as described in e.g. WO 92/19709 and WO 92/19708.
  • a polyol such as propylene glycol or glycerol
  • a sugar or sugar alcohol lactic acid, boric acid, or a boric acid derivative, e.g., an aromatic borate ester, or a phenyl boronic acid derivative such as 4-formylphenyl boronic acid
  • any single enzyme in particular the enzyme of the invention, may be added in an amount corresponding to 0.01-200 mg of enzyme protein per liter of wash liqour, preferably 0.05-50 mg of enzyme protein per liter of wash liqour, in particular 0.1-10 mg of enzyme protein per liter of wash liqour.
  • the enzyme of the invention may additionally be incorporated in the detergent formulations disclosed in WO 97/07202 which is hereby incorporated as reference.
  • Standard textile pieces are obtained from EMPA St. Gallen, Lerchfeldstrasse 5, CH-9014 St. Gallen, Switzerland. Especially type EMPA116 (cotton textile stained with blood, milk and ink) and EMPA117 (polyester/cotton textile stained with blood, milk and ink).
  • Bacillus lentus strain 309 is deposited with the NCIB and accorded the accession number NCIB 10309, and described in US Patent No. 3,723,250 incorporated by reference herein.
  • the parent subtilase 309 or Savinase® can be obtained from Strain 309.
  • the expression host organism is Bacillus subtilis.
  • the plasmid pSX222 is used as E. coli - B. subtilis shuttle vector and B. subtilis expression vector (as described in WO 96/34946).
  • Fermentations for the production of subtilase enzymes are performed at pH 7.3 and 37°C on a rotary s haking table at 225 rpm. i n 50 ml tubes containing 15 ml double TY media for 2-3 days.
  • the s ubtilase variant s ecreted from the h ost cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulfate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • WASH PERFORMANCE TEST In order to asses the wash performance of selected subtilase variants in detergent compositions, washing experiments are performed. The enzyme variants of the present application is tested using the Automatic Mechanical Stress Assay (AMSA). With the AMSA test the wash performance of a large quantity of small volume enzyme-detergent solutions can be examined.
  • the AMSA plate has a number of slots for test solutions and a lid firmly squeezing the textile swatch to be washed against all the slot openings. During the washing time, the plate, test solutions, textile and lid are vigorously shaken to bring the test solution in contact with the textile and apply mechanical stress.
  • WO 02/42740 especially the paragraph "Special method embodiments" at page 23-24.
  • Detergents for wash performance tests of the subtilase enzymes of the invention can be obtained by purchasing fully formulated commercial detergents at the market and subsequently inactivate the enzymatic components by heat treatment (5 minutes at 85°C in aqueous solution). Moreover a commercial detergent base without enzymes can be purchased directly from the manufacturer. Further a suitable model detergent can be composed according to the provisions at page 19-24 herein and used for wash performance tests.
  • Subtilisin 309 (Savinase ® ) site-directed variants of the invention comprising specific insertions/deletions/substitutions are made by traditional cloning of DNA fragments (Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989) produced by PCR with oligos containing the desired mutations.
  • the template plasmid DNA may be pSX222, or an analogue of this containing a variant of subtilisin 309. Mutations are introduced by oligo directed mutagenesis to the construction of variants.
  • the subtilisin 309 variants are transformed into E. coli.
  • DNA purified from an over night culture of t hese t ransformants is transformed i nto ⁇ . subtilis by restriction endonuclease digestion, purification of DNA fragments, ligation, transformation of B. subtilis. Transformation of B. subtilis is performed as described by Dubnau et al., 1971 , J. Mol. Biol. 56, pp. 209-221.
  • SITE-DIRECTED MUTAGENESIS IN ORDER TO INTRODUCE MUTATIONS IN A SPECIFIC REGION
  • Mutagenic primers are synthesized corresponding to the DNA sequence flanking the sites of mutation, separated by the DNA base pairs defining the insertions / deletions / substitutions.
  • the resulting mutagenic primers are used in a PCR reaction with the modified plasmid pSX222.
  • the resulting PCR fragment is purified and extended in a second PCR- reaction, the resulting PCR product is purified and extended in a third PCR-reaction before being digested by endonucleases and cloned into the E. coli - B. subtilis shuttle vector pSX222.
  • the PCR reactions are performed under normal conditions.
  • the plasmid DNA is transformed into E. coli by well-known techniques and one E. coli colony is sequenced to confirm the mutation designed.
  • subtilase variants of the invention can be constructed as described above.
  • the pSX222 expression plasmid comprising a variant of the invention was transformed into a competent ⁇ . subtilis strain and fermented as described above.
  • HCIC Hydrophobic Charge Induction Chromatography
  • the HCIC uses a cellulose matrix to which 4-Mercapto-Ethyl-Pyridine (4-MEP) is bound.
  • Beads of the cellulose matrix sized 80-100 ⁇ m are mixed with a media containing yeast extract and the transformed ⁇ . subtilis capable of secreting the subtilisin variants and incubated at pH
  • the concentration of the purified subtilisin enzyme variants is assessed by active site titration (AST).
  • the purified enzyme is incubated with the high affinity inhibitor CI-2A at different concentrations to inhibit a varying amount of the active sites.
  • the protease and inhibitor binds to each other at a 1 :1 ratio and accordingly the enzyme concentration can be directly related to the concentration of inhibitor, at which all protease is inactive.
  • a substrate 0.6 mM Suc-Ala-Ala-Pro-Phe-pNA in Tris/HCI buffer
  • a substrate 0.6 mM Suc-Ala-Ala-Pro-Phe-pNA in Tris/HCI buffer
  • p NA paranitrophenol
  • the performance of the enzyme variant is measured as the brightness of the colour of the textile samples washed with that specific enzyme variant. Brightness can also be expressed as the intensity of the light reflected from the textile sample when luminated with white light.
  • the intensity of the reflected light can be used to measure wash performance of an enzyme variant.
  • Colour measurements are made with a professional flatbed scanner (PFU DL2400pro), which is used to capture an image of the washed textile samples.
  • the scans are made with a resolution of 200 dpi and with an output colour dept of 24 bits.
  • the scanner is frequently calibrated with a Kodak reflective IT8 target.
  • a special designed software application is used (Novozymes Color Vector Analyzer).
  • the program retrieves the 24 bit pixel values from the image and converts them into values for red, green and blue (RGB).
  • RGB red, green and blue
  • T he intensity value (Int) is calculated by adding the RGB values together as vectors and then taking the length of the resulting vector:
  • wash performance (P) of the variants was calculated in accordance with the below formula:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP03769258A 2002-11-06 2003-11-05 Subtilasevarianten Withdrawn EP1563064A2 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP09172028.4A EP2138574B1 (de) 2002-11-06 2003-11-05 Subtilase Varianten
EP20100180046 EP2284258A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten
EP10183162.6A EP2399992A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK200201705 2002-11-06
DKPA200201705 2002-11-06
DKPA200201933 2002-12-18
DK200201933 2002-12-18
US50753703P 2003-10-01 2003-10-01
US507537P 2003-10-01
PCT/DK2003/000756 WO2004041979A2 (en) 2002-11-06 2003-11-05 Subtilase variants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP09172028.4A Division EP2138574B1 (de) 2002-11-06 2003-11-05 Subtilase Varianten

Publications (1)

Publication Number Publication Date
EP1563064A2 true EP1563064A2 (de) 2005-08-17

Family

ID=32314704

Family Applications (4)

Application Number Title Priority Date Filing Date
EP20100180046 Ceased EP2284258A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten
EP03769258A Withdrawn EP1563064A2 (de) 2002-11-06 2003-11-05 Subtilasevarianten
EP10183162.6A Withdrawn EP2399992A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten
EP09172028.4A Expired - Lifetime EP2138574B1 (de) 2002-11-06 2003-11-05 Subtilase Varianten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP20100180046 Ceased EP2284258A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP10183162.6A Withdrawn EP2399992A3 (de) 2002-11-06 2003-11-05 Subtilasevarianten
EP09172028.4A Expired - Lifetime EP2138574B1 (de) 2002-11-06 2003-11-05 Subtilase Varianten

Country Status (13)

Country Link
EP (4) EP2284258A3 (de)
JP (3) JP4694964B2 (de)
KR (4) KR20170037684A (de)
CN (3) CN101899428B (de)
AR (2) AR041993A1 (de)
AU (1) AU2003277836B2 (de)
BR (1) BR0315916A (de)
CA (1) CA2503965C (de)
CL (1) CL2010000493A1 (de)
MX (1) MXPA05004755A (de)
MY (1) MY140915A (de)
TW (1) TWI319007B (de)
WO (1) WO2004041979A2 (de)

Families Citing this family (284)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI319007B (en) * 2002-11-06 2010-01-01 Novozymes As Subtilase variants
US7888093B2 (en) 2002-11-06 2011-02-15 Novozymes A/S Subtilase variants
US20070161531A1 (en) 2005-07-08 2007-07-12 Novozymes A/S Subtilase variants
EP2385111B1 (de) * 2005-07-08 2016-09-07 Novozymes A/S Subtilasevarianten
US20090215663A1 (en) 2006-04-20 2009-08-27 Novozymes A/S Savinase variants having an improved wash performance on egg stains
KR20090031906A (ko) * 2006-07-18 2009-03-30 다니스코 유에스 인크. 광범위한 온도에 걸쳐 활성인 프로테아제 변이형
EP2272943B1 (de) * 2006-10-06 2018-02-28 Novozymes A/S Waschmittel und die Verwendung von Enzymkombinationen darin
EP2102335B1 (de) * 2007-01-04 2012-02-22 Crucell Holland B.V. Faktor-xi-reinigung
CN102046783A (zh) * 2008-06-06 2011-05-04 丹尼斯科美国公司 包含变体微生物蛋白酶的组合物和方法
GB0915572D0 (en) * 2009-09-07 2009-10-07 Reckitt Benckiser Nv Detergent composition
CN102648277B (zh) * 2009-09-25 2015-05-20 诺维信公司 蛋白酶变体的用途
CN102648273B (zh) * 2009-09-25 2017-04-26 诺维信公司 枯草蛋白酶变体
CN102652175B (zh) 2009-12-09 2016-02-10 宝洁公司 织物和家居护理产品
JP6448904B2 (ja) * 2010-05-06 2019-01-09 ダニスコ・ユーエス・インク サブチリシン変異体を含む組成物及び方法
FI123942B (fi) 2010-10-29 2013-12-31 Ab Enzymes Oy Sieniperäisen seriiniproteaasin variantteja
WO2012151480A2 (en) * 2011-05-05 2012-11-08 The Procter & Gamble Company Compositions and methods comprising serine protease variants
JP6105560B2 (ja) * 2011-05-05 2017-03-29 ダニスコ・ユーエス・インク セリンプロテアーゼ変異体を含む組成物及び方法
WO2013076269A1 (en) 2011-11-25 2013-05-30 Novozymes A/S Subtilase variants and polynucleotides encoding same
JP2015504660A (ja) 2011-12-20 2015-02-16 ノボザイムス アクティーゼルスカブ サブチラーゼ変異体およびそれをコードするポリヌクレオチド
EP2607468A1 (de) 2011-12-20 2013-06-26 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzungen mit Subtilasevarianten
EP2628785B1 (de) 2012-02-17 2016-05-18 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzungen mit Subtilasevarianten
WO2013120948A1 (en) 2012-02-17 2013-08-22 Novozymes A/S Subtilisin variants and polynucleotides encoding same
US20150132831A1 (en) 2012-05-16 2015-05-14 Novozymes A/S Compositions Comprising Lipase and Methods of Use Thereof
BR112014031882A2 (pt) 2012-06-20 2017-08-01 Novozymes As uso de um polipeptídeo isolado, polipeptídeo, composição, polinucleotídeo isolado, construto de ácido nucleico ou vetor de expressão, célula hospedeira de expressão recombinante, métodos para produção de um polipeptídeo, para melhoria do valor nutricional de uma ração animal, e para o tratamento de proteínas, uso de pelo menos um polipeptídeo, aditivo de ração animal, ração animal, e, composição detergente
US20150203793A1 (en) 2012-08-22 2015-07-23 Novozymes A/S Metalloprotease from Exiguobacterium
MX357022B (es) 2012-08-22 2018-06-25 Novozymes As Metaloproteasas de alicyclobacillus sp.
US20160145540A1 (en) 2012-08-22 2016-05-26 Novozymes A/S Detergent Compositions Comprising Metalloproteases
TR201910918T4 (tr) 2012-12-07 2019-08-21 Novozymes As Bakterilerin yapışmasının önlenmesi.
EP2934177B1 (de) 2012-12-21 2017-10-25 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide zur codierung davon
EP2941485B1 (de) 2013-01-03 2018-02-21 Novozymes A/S Alpha-amylase-varianten und polynukleotide zur codierung davon
EP4717756A2 (de) 2013-05-14 2026-04-01 Novozymes A/S Lipasevarianten und waschmittelzusammensetzungen
CN105209613A (zh) 2013-05-17 2015-12-30 诺维信公司 具有α淀粉酶活性的多肽
EP3004315A2 (de) 2013-06-06 2016-04-13 Novozymes A/S Alpha-amylase-varianten und polynukleotide zur codierung davon
EP3013950B1 (de) 2013-06-27 2018-08-08 Novozymes A/S Subtilasevarianten und polynucleotide, die diese codieren
US20160145596A1 (en) 2013-06-27 2016-05-26 Novozymes A/S Subtilase Variants and Polynucleotides Encoding Same
US10378001B2 (en) 2013-06-27 2019-08-13 Novozymes A/S Subtilase variants and compositions comprising same
RU2015156280A (ru) 2013-07-04 2017-08-09 Новозимс А/С Полипептиды, обладающие эффектом против переосаждения, и полинуклеотиды, кодирующие их
WO2015004102A1 (en) 2013-07-09 2015-01-15 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
CN105358686A (zh) 2013-07-29 2016-02-24 诺维信公司 蛋白酶变体以及对其进行编码的多核苷酸
WO2015014803A1 (en) 2013-07-29 2015-02-05 Novozymes A/S Protease variants and polynucleotides encoding same
WO2015049370A1 (en) 2013-10-03 2015-04-09 Novozymes A/S Detergent composition and use of detergent composition
EP3453757B1 (de) 2013-12-20 2020-06-17 Novozymes A/S Polypeptide mit proteaseaktivität und polynukleotide, die für diese kodieren
US10208297B2 (en) 2014-01-22 2019-02-19 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same for cleaning
WO2015134729A1 (en) 2014-03-05 2015-09-11 Novozymes A/S Compositions and methods for improving properties of non-cellulosic textile materials with xyloglucan endotransglycosylase
CN106062271A (zh) 2014-03-05 2016-10-26 诺维信公司 用于改进具有木葡聚糖内糖基转移酶的纤维素纺织材料的性质的组合物和方法
EP3521434A1 (de) 2014-03-12 2019-08-07 Novozymes A/S Polypeptide mit lipaseaktivität und polynukleotide zur codierung davon
US20170015950A1 (en) 2014-04-01 2017-01-19 Novozymes A/S Polypeptides having alpha amylase activity
MX376770B (es) 2014-04-11 2025-03-07 Novozymes As Composición detergente.
WO2015158237A1 (en) 2014-04-15 2015-10-22 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
WO2017186943A1 (en) 2016-04-29 2017-11-02 Novozymes A/S Detergent compositions and uses thereof
WO2015181118A1 (en) 2014-05-27 2015-12-03 Novozymes A/S Methods for producing lipases
AR100606A1 (es) 2014-05-27 2016-10-19 Novozymes As Variantes de lipasas y polinucleótidos que las codifican
WO2015189371A1 (en) 2014-06-12 2015-12-17 Novozymes A/S Alpha-amylase variants and polynucleotides encoding same
EP3739029A1 (de) 2014-07-04 2020-11-18 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
US10550381B2 (en) 2014-07-04 2020-02-04 Novozymes A/S Variant proteases and amylases having enhanced storage stability
WO2016079110A2 (en) 2014-11-19 2016-05-26 Novozymes A/S Use of enzyme for cleaning
WO2016087401A1 (en) 2014-12-05 2016-06-09 Novozymes A/S Lipase variants and polynucleotides encoding same
EP4530348A3 (de) 2014-12-15 2025-08-06 Basf Se Waschmittelzusammensetzung mit subtilasevarianten
WO2016096711A2 (en) 2014-12-15 2016-06-23 Novozymes A/S Subtilase variants
CN107002049A (zh) 2014-12-16 2017-08-01 诺维信公司 具有n‑乙酰基葡萄糖胺氧化酶活性的多肽
US11518987B2 (en) 2014-12-19 2022-12-06 Novozymes A/S Protease variants and polynucleotides encoding same
US10400230B2 (en) 2014-12-19 2019-09-03 Novozymes A/S Protease variants and polynucleotides encoding same
CN107636134A (zh) 2015-04-10 2018-01-26 诺维信公司 洗涤剂组合物
US20180112156A1 (en) 2015-04-10 2018-04-26 Novozymes A/S Laundry method, use of polypeptide and detergent composition
EP3298121B1 (de) 2015-05-19 2019-03-20 Novozymes A/S Geruchsreduzierung
BR112017025607B1 (pt) 2015-06-02 2022-08-30 Unilever Ip Holdings B.V. Composição de detergente para lavagem de roupas e método doméstico de tratamento de um tecido
EP3287513A1 (de) 2015-06-04 2018-02-28 The Procter & Gamble Company Handspülflüssigreinigungszusammensetzung
ES2670044T3 (es) 2015-06-04 2018-05-29 The Procter & Gamble Company Composición detergente líquida para lavado de vajillas a mano
EP3101102B2 (de) 2015-06-05 2023-12-13 The Procter & Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
EP3101100B1 (de) 2015-06-05 2018-02-07 The Procter and Gamble Company Kompaktierte flüssige waschmittelzusammensetzung
EP3101107B1 (de) 2015-06-05 2019-04-24 The Procter and Gamble Company Kompaktierte flüssigwaschmittelzusammensetzung
WO2016198262A1 (en) 2015-06-11 2016-12-15 Unilever Plc Laundry detergent composition
US10858637B2 (en) 2015-06-16 2020-12-08 Novozymes A/S Polypeptides with lipase activity and polynucleotides encoding same
EP3310688A1 (de) 2015-06-17 2018-04-25 Novozymes A/S Behälter
EP3106508B1 (de) 2015-06-18 2019-11-20 Henkel AG & Co. KGaA Reinigungsmittelzusammensetzung mit subtilasevarianten
EP4071244A1 (de) 2015-06-18 2022-10-12 Novozymes A/S Subtilasevarianten und polynukleotide zur codierung davon
EP3313966B1 (de) 2015-06-26 2020-07-29 Unilever PLC Waschmittelzusammensetzung
CN107922896A (zh) 2015-06-30 2018-04-17 诺维信公司 衣物洗涤剂组合物、用于洗涤的方法和组合物的用途
MX394221B (es) 2015-07-01 2025-03-24 Novozymes As Metodos de reduccion de olor.
EP3950939A3 (de) 2015-07-06 2022-06-08 Novozymes A/S Lipasevarianten und polynukleotide zur codierung davon
US20180171269A1 (en) * 2015-09-01 2018-06-21 Novozymes A/S Laundry method
CA2991114A1 (en) 2015-09-17 2017-03-23 Novozymes A/S Polypeptides having xanthan degrading activity and polynucleotides encoding same
US11053486B2 (en) 2015-09-17 2021-07-06 Henkel Ag & Co. Kgaa Detergent compositions comprising polypeptides having xanthan degrading activity
BR112018006212B1 (pt) 2015-10-01 2022-04-12 Unilever Ip Holdings B.V. Composição de detergente em pó formada por carbonato sem fosfato e método de tratamento doméstico de um tecido
EP3359657B1 (de) 2015-10-07 2020-04-01 Novozymes A/S Polypeptide
EP3362558A1 (de) 2015-10-14 2018-08-22 Novozymes A/S Polypeptide mit proteaseaktivität und dafür codierende polynukleotide
EP4324919A3 (de) 2015-10-14 2024-05-29 Novozymes A/S Polypeptidvarianten
JP2018531783A (ja) 2015-10-14 2018-11-01 ノボザイムス アクティーゼルスカブ 水濾過膜の洗浄
CN108291178B (zh) 2015-10-28 2020-08-04 诺维信公司 包含淀粉酶变体和蛋白酶变体的洗涤剂组合物
WO2017089366A1 (en) 2015-11-24 2017-06-01 Novozymes A/S Polypeptides having protease activity and polynucleotides encoding same
WO2017093318A1 (en) 2015-12-01 2017-06-08 Novozymes A/S Methods for producing lipases
ES2932192T3 (es) 2015-12-07 2023-01-16 Henkel Ag & Co Kgaa Composiciones para el lavado de vajilla que comprenden polipéptidos que tienen actividad beta-glucanasa y sus usos
MX2018008051A (es) 2016-01-29 2018-08-23 Novozymes As Variantes de beta-glucanasa y polinucleotidos que las codifican.
CN108603140B (zh) 2016-02-17 2020-09-08 荷兰联合利华有限公司 增白组合物
BR112018068068B1 (pt) 2016-03-21 2023-04-18 Unilever Ip Holdings B.V. Composição aquosa líquida de detergente para lavagem de roupas e método doméstico de tratamento de um tecido
WO2017162836A1 (en) 2016-03-23 2017-09-28 Novozymes A/S Use of polypeptide having dnase activity for treating fabrics
EP3440172B1 (de) 2016-04-08 2019-08-21 Unilever PLC Wäschewaschmittelzusammensetzung
EP3440180B1 (de) 2016-04-08 2020-11-11 Novozymes A/S Detergenszusammensetzungen und verwendungen derselben
CN109072213A (zh) * 2016-05-05 2018-12-21 丹尼斯科美国公司 蛋白酶变体及其用途
WO2017210188A1 (en) 2016-05-31 2017-12-07 Novozymes A/S Stabilized liquid peroxide compositions
EP3475404A1 (de) 2016-06-23 2019-05-01 Novozymes A/S Verwendung von enzymen, zusammensetzung und verfahren zum entfernen von schmutz
US11203732B2 (en) 2016-06-30 2021-12-21 Novozymes A/S Lipase variants and compositions comprising surfactant and lipase variant
WO2018002261A1 (en) 2016-07-01 2018-01-04 Novozymes A/S Detergent compositions
WO2018007573A1 (en) 2016-07-08 2018-01-11 Novozymes A/S Detergent compositions with galactanase
CA3027272C (en) 2016-07-13 2022-06-21 The Procter & Gamble Company Bacillus cibi dnase variants and uses thereof
EP3485008B1 (de) 2016-07-18 2024-01-31 Novozymes A/S Lipasevarianten, polynukleotide zur codierung davon und verwendung davon
CN109563447A (zh) 2016-08-08 2019-04-02 巴斯夫欧洲公司 液体洗衣制剂
ES2790148T3 (es) 2016-08-17 2020-10-27 Procter & Gamble Composición limpiadora que comprende enzimas
EP3519542B1 (de) 2016-09-27 2020-02-19 Unilever PLC Waschverfahren für den haushalt
CN110023474A (zh) 2016-09-29 2019-07-16 诺维信公司 酶用于洗涤的用途、洗涤方法和器皿洗涤组合物
WO2018060475A1 (en) 2016-09-29 2018-04-05 Novozymes A/S Spore containing granule
US20210284933A1 (en) 2016-10-25 2021-09-16 Novozymes A/S Detergent compositions
CN110072986B (zh) 2016-11-01 2023-04-04 诺维信公司 多核心颗粒
MX2019006425A (es) 2016-12-01 2019-08-14 Basf Se Estabilizacion de enzimas en composiciones.
EP3551740B1 (de) 2016-12-12 2021-08-11 Novozymes A/S Verwendung von polypeptiden
BR112019011999B1 (pt) 2016-12-15 2022-11-08 Unilever Ip Holdings B.V Composição de detergente líquida aquosa para lavagem de roupas e método doméstico de tratamento de um tecido
US11149233B2 (en) 2017-03-31 2021-10-19 Novozymes A/S Polypeptides having RNase activity
CN110651040A (zh) 2017-03-31 2020-01-03 诺维信公司 具有dna酶活性的多肽
WO2018177936A1 (en) 2017-03-31 2018-10-04 Novozymes A/S Polypeptides having dnase activity
US11208639B2 (en) 2017-03-31 2021-12-28 Novozymes A/S Polypeptides having DNase activity
EP3607039A1 (de) 2017-04-04 2020-02-12 Novozymes A/S Polypeptide
CN114480034A (zh) 2017-04-04 2022-05-13 诺维信公司 糖基水解酶
EP3607040A1 (de) 2017-04-04 2020-02-12 Novozymes A/S Polypeptidzusammensetzungen und verwendungen davon
ES2728758T3 (es) 2017-04-05 2019-10-28 Henkel Ag & Co Kgaa Composiciones de detergente que comprenden mananasas bacterianas
EP3385362A1 (de) 2017-04-05 2018-10-10 Henkel AG & Co. KGaA Waschmittelzusammensetzungen mit pilzmannanasen
WO2018185269A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
EP3967756B1 (de) 2017-04-06 2025-03-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
EP3478811B1 (de) 2017-04-06 2019-10-16 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
EP3607044B1 (de) 2017-04-06 2024-11-13 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
WO2018184816A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
US20200190438A1 (en) 2017-04-06 2020-06-18 Novozymes A/S Cleaning compositions and uses thereof
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018202846A1 (en) 2017-05-05 2018-11-08 Novozymes A/S Compositions comprising lipase and sulfite
WO2018224544A1 (en) 2017-06-08 2018-12-13 Novozymes A/S Compositions comprising polypeptides having cellulase activity and amylase activity, and uses thereof in cleaning and detergent compositions
EP3645692B1 (de) 2017-06-30 2025-12-31 Novozymes A/S Enzymschlammzusammensetzung
WO2019018976A1 (en) 2017-07-24 2019-01-31 Rhodia Operations DETERGENT COMPOSITION CONTAINING ENZYMES
WO2019057758A1 (en) 2017-09-20 2019-03-28 Novozymes A/S USE OF ENZYMES TO ENHANCE WATER ABSORPTION AND / OR WHITENESS
EP3684899A1 (de) 2017-09-22 2020-07-29 Novozymes A/S Neuartige polypeptide
EP4567094A3 (de) 2017-09-27 2026-01-07 Novozymes A/S Lipasevarianten und mikrokapselzusammensetzungen mit solchen lipasevarianten
JP7114697B2 (ja) 2017-09-27 2022-08-08 ザ プロクター アンド ギャンブル カンパニー リパーゼを含む洗剤組成物
US11746310B2 (en) 2017-10-02 2023-09-05 Novozymes A/S Polypeptides having mannanase activity and polynucleotides encoding same
CN111373036A (zh) 2017-10-02 2020-07-03 诺维信公司 具有甘露聚糖酶活性的多肽和编码它们的多核苷酸
WO2019076800A1 (en) 2017-10-16 2019-04-25 Novozymes A/S CLEANING COMPOSITIONS AND USES THEREOF
CN111542589A (zh) 2017-10-16 2020-08-14 诺维信公司 低粉化颗粒
EP3697881B1 (de) 2017-10-16 2024-12-18 Novozymes A/S Staubarme granulate
WO2019081515A1 (en) 2017-10-24 2019-05-02 Novozymes A/S COMPOSITIONS COMPRISING POLYPEPTIDES HAVING MANNANASE ACTIVITY
EP3701017A1 (de) 2017-10-27 2020-09-02 Novozymes A/S Dnase-varianten
HUE057832T2 (hu) 2017-10-27 2022-06-28 Procter & Gamble Polipeptid-variánsokat tartalmazó mosószerkészítmények
DE102017125560A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine iii enthalten
EP3704220B1 (de) 2017-11-01 2026-04-15 Novozymes A/S Verfahren zur reinigung von medizinischen geräten
DE102017125558A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine i enthalten
WO2019086530A1 (en) 2017-11-01 2019-05-09 Novozymes A/S Polypeptides and compositions comprising such polypeptides
EP3704240A1 (de) 2017-11-01 2020-09-09 Novozymes A/S Polypeptide und zusammensetzungen mit solchen polypeptiden
DE102017125559A1 (de) 2017-11-01 2019-05-02 Henkel Ag & Co. Kgaa Reinigungszusammensetzungen, die dispersine ii enthalten
CN111465680A (zh) 2017-11-29 2020-07-28 巴斯夫欧洲公司 组合物、其制备和用途
CN111670248A (zh) 2017-12-04 2020-09-15 诺维信公司 脂肪酶变体以及编码其的多核苷酸
EP3749759A1 (de) 2018-02-08 2020-12-16 Novozymes A/S Lipasevarianten und zusammensetzungen davon
WO2019154951A1 (en) 2018-02-08 2019-08-15 Novozymes A/S Lipases, lipase variants and compositions thereof
EP3781660A1 (de) 2018-04-17 2021-02-24 Novozymes A/S Polypeptide mit kohlenhydratbindungsaktivität in waschmittelzusammensetzungen und ihre verwendung zur verminderung von falten in textilien oder geweben
EP3781680A1 (de) 2018-04-19 2021-02-24 Novozymes A/S Stabilisierte cellulase-varianten
CN118460512A (zh) 2018-04-19 2024-08-09 诺维信公司 稳定化的纤维素酶变体
US11732250B2 (en) 2018-04-26 2023-08-22 Basf Se Lipase enzymes
WO2019211143A1 (en) 2018-05-03 2019-11-07 Basf Se Amylase enzymes
WO2019238761A1 (en) 2018-06-15 2019-12-19 Basf Se Water soluble multilayer films containing wash active chemicals and enzymes
EP3814472A1 (de) 2018-06-28 2021-05-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
EP3814473A1 (de) 2018-06-29 2021-05-05 Novozymes A/S Reinigungsmittelzusammensetzungen und verwendungen davon
US12012573B2 (en) 2018-07-02 2024-06-18 Novozymes A/S Cleaning compositions and uses thereof
EP3818138B1 (de) 2018-07-03 2025-05-14 Henkel AG & Co. KGaA Enzymhaltige reinigungszusammensetzungen und verwendungen davon
WO2020008024A1 (en) 2018-07-06 2020-01-09 Novozymes A/S Cleaning compositions and uses thereof
WO2020030623A1 (en) 2018-08-10 2020-02-13 Basf Se Packaging unit comprising a detergent composition containing an enzyme and at least one chelating agent
WO2020070063A2 (en) 2018-10-01 2020-04-09 Novozymes A/S Detergent compositions and uses thereof
WO2020070209A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition
EP3861094A1 (de) 2018-10-02 2021-08-11 Novozymes A/S Reinigungszusammensetzung
WO2020070014A1 (en) 2018-10-02 2020-04-09 Novozymes A/S Cleaning composition comprising anionic surfactant and a polypeptide having rnase activity
CN112969788A (zh) 2018-10-02 2021-06-15 诺维信公司 用于清洁的核酸内切酶1核糖核酸酶
WO2020070199A1 (en) 2018-10-03 2020-04-09 Novozymes A/S Polypeptides having alpha-mannan degrading activity and polynucleotides encoding same
WO2020070249A1 (en) 2018-10-03 2020-04-09 Novozymes A/S Cleaning compositions
EP3677676A1 (de) 2019-01-03 2020-07-08 Basf Se Verbindungen zur stabilisierung von amylasen in flüssigkeiten
CN112805377A (zh) 2018-10-05 2021-05-14 巴斯夫欧洲公司 在液体中稳定淀粉酶的化合物
US20210395651A1 (en) 2018-10-05 2021-12-23 Basf Se Compounds stabilizing hydrolases in liquids
BR112021005412A2 (pt) 2018-10-05 2021-06-15 Basf Se preparação de enzima, processo para fabricar uma preparação de enzima estável, métodos para reduzir a perda da atividade proteolítica, para preparação de uma formulação detergente, para remover manchas e para aumentar a estabilidade na armazenagem de uma formulação detergente líquida, usos de um composto e da preparação de enzima, e, formulação detergente
CN112996894A (zh) 2018-10-11 2021-06-18 诺维信公司 清洁组合物及其用途
EP3647398B1 (de) 2018-10-31 2024-05-15 Henkel AG & Co. KGaA Reinigungszusammensetzungen mit dispersinen v
EP3647397A1 (de) 2018-10-31 2020-05-06 Henkel AG & Co. KGaA Reinigungsmittel mit dispersins iv
WO2020104231A1 (en) 2018-11-19 2020-05-28 Basf Se Powders and granules containing a chelating agent and an enzyme
CN113302270A (zh) 2018-12-03 2021-08-24 诺维信公司 低pH粉末洗涤剂组合物
EP3898919A1 (de) 2018-12-21 2021-10-27 Novozymes A/S Waschmittelbeutel mit metalloproteasen
CN113366103A (zh) 2018-12-21 2021-09-07 诺维信公司 具有肽聚糖降解活性的多肽以及编码其的多核苷酸
MX2021008891A (es) * 2019-01-28 2021-08-19 Novozymes As Variantes de subtilasa y composiciones que las comprenden.
CN114096676A (zh) 2019-02-20 2022-02-25 巴斯夫欧洲公司 用确定成分培养基和镁补料的芽孢杆菌工业发酵工艺
WO2020169564A1 (en) 2019-02-20 2020-08-27 Basf Se Industrial fermentation process for bacillus using defined medium and trace element feed
JP7725365B2 (ja) 2019-03-21 2025-08-19 ノボザイムス アクティーゼルスカブ α－アミラーゼ変異体及びこれをコードするポリヌクレオチド
WO2020201403A1 (en) 2019-04-03 2020-10-08 Novozymes A/S Polypeptides having beta-glucanase activity, polynucleotides encoding same and uses thereof in cleaning and detergent compositions
US12247237B2 (en) 2019-04-10 2025-03-11 Novozymes A/S Polypeptide variants
WO2020208056A1 (en) 2019-04-12 2020-10-15 Novozymes A/S Stabilized glycoside hydrolase variants
WO2020229480A1 (en) 2019-05-14 2020-11-19 Basf Se Compounds stabilizing hydrolases in liquids
US12146171B2 (en) 2019-06-13 2024-11-19 Basf Se Method of recovering a protein from fermentation broth using a divalent cation
CN114008068A (zh) 2019-07-01 2022-02-01 巴斯夫欧洲公司 稳定酶的肽缩醛
US20220340865A1 (en) 2019-07-02 2022-10-27 Basf Se Method for preparing a fermentation medium
EP3994255A1 (de) 2019-07-02 2022-05-11 Novozymes A/S Lipasevarianten und zusammensetzungen davon
WO2021004830A1 (en) 2019-07-05 2021-01-14 Basf Se Industrial fermentation process for microbial cells using a fed-batch pre-culture
EP3997202A1 (de) 2019-07-12 2022-05-18 Novozymes A/S Enzymatische emulsionen für reinigungsmittel
WO2021030400A1 (en) 2019-08-13 2021-02-18 Novozymes Bioag A/S Pesticidal combinations of yersinia and proteases
WO2021037878A1 (en) 2019-08-27 2021-03-04 Novozymes A/S Composition comprising a lipase
CN114787329A (zh) 2019-08-27 2022-07-22 诺维信公司 洗涤剂组合物
EP4031644A1 (de) 2019-09-19 2022-07-27 Novozymes A/S Reinigungsmittelzusammensetzung
WO2021064068A1 (en) 2019-10-03 2021-04-08 Novozymes A/S Polypeptides comprising at least two carbohydrate binding domains
BR112022006082A2 (pt) 2019-10-18 2022-06-21 Basf Se Preparação enzimática, formulação de detergente, e, uso de pelo menos um diol
WO2021105336A1 (en) 2019-11-29 2021-06-03 Basf Se Compositions comprising polymer and enzyme
WO2021115912A1 (en) 2019-12-09 2021-06-17 Basf Se Formulations comprising a hydrophobically modified polyethyleneimine and one or more enzymes
KR20220119609A (ko) 2019-12-20 2022-08-30 헨켈 아게 운트 코. 카게아아 디스페르신 vi을 포함하는 세정 조성물
US20220411773A1 (en) 2019-12-20 2022-12-29 Novozymes A/S Polypeptides having proteolytic activity and use thereof
WO2021122117A1 (en) 2019-12-20 2021-06-24 Henkel Ag & Co. Kgaa Cleaning composition coprising a dispersin and a carbohydrase
EP4077617B1 (de) 2019-12-20 2026-03-18 Novozymes A/S Stabilisierte flüssige borfreie enzymzusammensetzungen
AU2020405786A1 (en) 2019-12-20 2022-08-11 Henkel Ag & Co. Kgaa Cleaning compositions comprising dispersins IX
WO2021151536A1 (en) 2020-01-29 2021-08-05 Unilever Ip Holdings B.V. Laundry detergent product
EP4097227A1 (de) 2020-01-31 2022-12-07 Novozymes A/S Mannanase-varianten und dafür codierende polynukleotide
WO2021152120A1 (en) 2020-01-31 2021-08-05 Novozymes A/S Mannanase variants and polynucleotides encoding same
CN115066495A (zh) 2020-02-14 2022-09-16 巴斯夫欧洲公司 甘露聚糖酶变体
EP3892708A1 (de) 2020-04-06 2021-10-13 Henkel AG & Co. KGaA Reinigungszusammensetzungen mit dispersinvarianten
WO2021204838A1 (en) 2020-04-08 2021-10-14 Novozymes A/S Carbohydrate binding module variants
US20230167384A1 (en) 2020-04-21 2023-06-01 Novozymes A/S Cleaning compositions comprising polypeptides having fructan degrading activity
PL4168523T3 (pl) 2020-06-18 2024-11-04 Basf Se Kompozycje i ich zastosowanie
EP4172298A1 (de) 2020-06-24 2023-05-03 Novozymes A/S Verwendung von cellulasen zur entfernung von staubmilben aus textilien
EP3936593A1 (de) 2020-07-08 2022-01-12 Henkel AG & Co. KGaA Reinigungszusammensetzungen und verwendungen davon
EP4179053B1 (de) 2020-07-09 2024-04-03 Basf Se Zusammensetzungen und deren anwendungen
WO2022008732A1 (en) 2020-07-10 2022-01-13 Basf Se Enhancing the activity of antimicrobial preservatives
WO2022023250A1 (en) 2020-07-27 2022-02-03 Unilever Ip Holdings B.V. Use of an enzyme and surfactant for inhibiting microorganisms
EP4204551B1 (de) 2020-08-25 2025-09-17 Novozymes A/S Varianten einer familie44-xyloglucanase
WO2022043563A1 (en) * 2020-08-28 2022-03-03 Novozymes A/S Polyester degrading protease variants
CN116113329A (zh) 2020-09-15 2023-05-12 诺维信公司 包含昆虫或昆虫粉的动物饲料
US20250346879A1 (en) 2020-10-07 2025-11-13 Novozymes A/S Alpha-amylase variants
WO2022084303A2 (en) 2020-10-20 2022-04-28 Novozymes A/S Use of polypeptides having dnase activity
WO2022083949A1 (en) 2020-10-20 2022-04-28 Basf Se Compositions and their use
WO2022090320A1 (en) 2020-10-28 2022-05-05 Novozymes A/S Use of lipoxygenase
JP2023547450A (ja) 2020-10-29 2023-11-10 ノボザイムス アクティーゼルスカブ リパーゼ変異体及びそのようなリパーゼ変異体を含む組成物
EP4244325A1 (de) 2020-11-13 2023-09-20 Novozymes A/S Waschmittelzusammensetzung mit lipase
WO2022106400A1 (en) 2020-11-18 2022-05-27 Novozymes A/S Combination of immunochemically different proteases
EP4032966A1 (de) 2021-01-22 2022-07-27 Novozymes A/S Flüssige enzymzusammensetzung mit sulfitabfänger
US20240124805A1 (en) 2021-01-28 2024-04-18 Novozymes A/S Lipase with low malodor generation
EP4291646A2 (de) 2021-02-12 2023-12-20 Novozymes A/S Alpha-amylase-varianten
US20250075152A1 (en) 2021-02-12 2025-03-06 Novozymes A/S Stabilized biological detergents
EP4305146A1 (de) 2021-03-12 2024-01-17 Novozymes A/S Polypeptidvarianten
WO2022194673A1 (en) 2021-03-15 2022-09-22 Novozymes A/S Dnase variants
EP4060036A1 (de) 2021-03-15 2022-09-21 Novozymes A/S Polypeptidvarianten
WO2022199418A1 (en) 2021-03-26 2022-09-29 Novozymes A/S Detergent composition with reduced polymer content
EP4359518A1 (de) 2021-06-23 2024-05-01 Novozymes A/S Alpha-amylase-polypeptide
CN118202030A (zh) 2021-10-13 2024-06-14 巴斯夫欧洲公司 包含聚合物的组合物、聚合物及其用途
WO2023066741A1 (en) 2021-10-20 2023-04-27 Basf Se Phosphate-free composition and methods for their manufacture and use
MX2024006196A (es) 2021-11-22 2024-06-11 Basf Se Composiciones que comprenden polimeros, polimeros y su uso.
CN118451167A (zh) 2021-11-22 2024-08-06 巴斯夫欧洲公司 包含聚合物的组合物、聚合物及其用途
WO2023110599A2 (en) 2021-12-17 2023-06-22 Basf Se Compositions and their applications
WO2023117888A1 (en) 2021-12-21 2023-06-29 Basf Se Chemical product passport for emission data
CN118871559A (zh) 2021-12-21 2024-10-29 诺维信公司 包含脂肪酶和加强剂的组合物
EP4206309A1 (de) 2021-12-30 2023-07-05 Novozymes A/S Proteinpartikel mit verbesserter weisse
EP4234664A1 (de) 2022-02-24 2023-08-30 Evonik Operations GmbH Zusammensetzung mit glucolipiden und enzymen
US20250179393A1 (en) 2022-03-02 2025-06-05 Novozymes A/S Use of xyloglucanase for improvement of sustainability of detergents
WO2023165950A1 (en) 2022-03-04 2023-09-07 Novozymes A/S Dnase variants and compositions
EP4504885A1 (de) 2022-04-08 2025-02-12 Novozymes A/S Hexosaminidase-varianten und -zusammensetzungen
WO2023233025A1 (en) 2022-06-03 2023-12-07 Unilever Ip Holdings B.V. Liquid detergent product
WO2023247348A1 (en) 2022-06-21 2023-12-28 Novozymes A/S Mannanase variants and polynucleotides encoding same
EP4544015A2 (de) 2022-06-24 2025-04-30 Novozymes A/S Lipasevarianten und zusammensetzungen mit solchen lipasevarianten
CN119585409A (zh) 2022-07-15 2025-03-07 巴斯夫欧洲公司 用于液体配制品中酶稳定的烷醇胺甲酸盐
WO2024083589A1 (en) 2022-10-18 2024-04-25 Basf Se Detergent compositions, polymers and methods of manufacturing the same
EP4630529A1 (de) 2022-12-05 2025-10-15 Novozymes A/S Zusammensetzung mit einer lipase und einem peptid
CN120265743A (zh) 2022-12-14 2025-07-04 诺维信公司 改善的脂肪酶（gcl1）变体
EP4389864A1 (de) 2022-12-20 2024-06-26 Basf Se Cutinasen
CN120344647A (zh) 2022-12-23 2025-07-18 诺维信公司 包含过氧化氢酶和淀粉酶的洗涤剂组合物
EP4655371A1 (de) 2023-01-23 2025-12-03 Novozymes A/S Reinigungszusammensetzungen und verwendungen davon
EP4683990A1 (de) 2023-03-21 2026-01-28 Novozymes A/S Waschmittelzusammensetzungen auf basis von biotensiden
WO2024213513A1 (en) 2023-04-12 2024-10-17 Novozymes A/S Compositions comprising polypeptides having alkaline phosphatase activity
EP4702114A2 (de) 2023-04-26 2026-03-04 Novozymes A/S Reinigungszusammensetzung und reinigungsverfahren
EP4461795A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
EP4461796A1 (de) 2023-05-10 2024-11-13 Novozymes A/S Laccase enthaltendes waschmittel
WO2024231483A1 (en) 2023-05-11 2024-11-14 Novozymes A/S Automatic dishwashing detergent compositions comprising a lipase
WO2025002934A1 (en) 2023-06-28 2025-01-02 Novozymes A/S Detergent composition comprising lipases
CN121420051A (zh) 2023-07-07 2026-01-27 诺维信公司 用于去除蛋白质污渍的洗涤方法
WO2025088003A1 (en) 2023-10-24 2025-05-01 Novozymes A/S Use of xyloglucanase for replacement of optical brightener
WO2025103765A1 (en) 2023-11-17 2025-05-22 Novozymes A/S Lytic polysaccharide monooxygenases and their use in detergent
WO2025114053A1 (en) 2023-11-30 2025-06-05 Novozymes A/S Biopolymers for use in detergent
WO2025132258A1 (en) 2023-12-20 2025-06-26 Basf Se Stabilized enzyme composition comprising a protease
WO2025257254A1 (en) 2024-06-12 2025-12-18 Novozymes A/S Lipases and lipase variants and the use thereof
WO2026017636A1 (en) 2024-07-17 2026-01-22 Novozymes A/S Compositions comprising combination of enzymes
WO2026046881A1 (en) 2024-08-26 2026-03-05 Novozymes A/S Compositions comprising a hexosaminidase and a protease

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE80993C (de) 1894-09-03
GB1234445A (de) 1967-10-03 1971-06-03
GB1296839A (de) 1969-05-29 1972-11-22
GB1372034A (en) 1970-12-31 1974-10-30 Unilever Ltd Detergent compositions
GB1483591A (en) 1973-07-23 1977-08-24 Novo Industri As Process for coating water soluble or water dispersible particles by means of the fluid bed technique
GB1590432A (en) 1976-07-07 1981-06-03 Novo Industri As Process for the production of an enzyme granulate and the enzyme granuate thus produced
DK187280A (da) 1980-04-30 1981-10-31 Novo Industri As Ruhedsreducerende middel til et fuldvaskemiddel fuldvaskemiddel og fuldvaskemetode
DK263584D0 (da) 1984-05-29 1984-05-29 Novo Industri As Enzymholdige granulater anvendt som detergentadditiver
JPH0697997B2 (ja) 1985-08-09 1994-12-07 ギスト ブロカデス ナ−ムロ−ゼ フエンノ−トチヤツプ 新規の酵素的洗浄剤添加物
EG18543A (en) 1986-02-20 1993-07-30 Albright & Wilson Protected enzyme systems
DE3750450T2 (de) 1986-08-29 1995-01-05 Novo Industri As Enzymhaltiger Reinigungsmittelzusatz.
NZ221627A (en) 1986-09-09 1993-04-28 Genencor Inc Preparation of enzymes, modifications, catalytic triads to alter ratios or transesterification/hydrolysis ratios
EP0305216B1 (de) 1987-08-28 1995-08-02 Novo Nordisk A/S Rekombinante Humicola-Lipase und Verfahren zur Herstellung von rekombinanten Humicola-Lipasen
DK6488D0 (da) 1988-01-07 1988-01-07 Novo Industri As Enzymer
DE68924654T2 (de) 1988-01-07 1996-04-04 Novonordisk As Spezifische Protease.
JP3079276B2 (ja) 1988-02-28 2000-08-21 天野製薬株式会社 組換え体ｄｎａ、それを含むシュードモナス属菌及びそれを用いたリパーゼの製造法
US5648263A (en) 1988-03-24 1997-07-15 Novo Nordisk A/S Methods for reducing the harshness of a cotton-containing fabric
JP2728531B2 (ja) 1988-03-24 1998-03-18 ノボ ノルディスク アクティーゼルスカブ セルラーゼ調製品
BR9006832A (pt) * 1989-06-26 1991-08-06 Unilever Nv Composicao detergente enzimatica
DK316989D0 (da) 1989-06-26 1989-06-26 Novo Nordisk As Enzymer
GB8915658D0 (en) 1989-07-07 1989-08-23 Unilever Plc Enzymes,their production and use
KR100236540B1 (ko) 1990-04-14 2000-01-15 레클로우크스 라우에르 알카리성 바실러스-리파제, 이를 코-딩하는 dna 서열 및 리파제를 생산하는 바실러스 균주
DK115890D0 (da) 1990-05-09 1990-05-09 Novo Nordisk As Enzym
DK0531372T4 (da) 1990-05-09 2004-08-09 Novozymes As Cellulasepræparat omfattende et endoglucanaseenzym
AU657278B2 (en) 1990-09-13 1995-03-09 Novo Nordisk A/S Lipase variants
ES2174820T3 (es) 1991-01-16 2002-11-16 Procter & Gamble Composiciones detergentes compactas con celulasa de alta actividad.
CZ285148B6 (cs) 1991-04-30 1999-05-12 The Procter And Gamble Company Kapalné detergentní směsi s borito-polyolovým komplexem k inhibici proteolytického enzymu
EP0511456A1 (de) 1991-04-30 1992-11-04 The Procter & Gamble Company Flüssiges Reinigungsmittel mit einem aromatischen Boratester zur Inhibierung des proteolytischen Enzyms
ES2121014T3 (es) 1991-05-01 1998-11-16 Novo Nordisk As Enzimas estabilizadas y composiciones detergentes.
DK72992D0 (da) 1992-06-01 1992-06-01 Novo Nordisk As Enzym
DK88892D0 (da) 1992-07-06 1992-07-06 Novo Nordisk As Forbindelse
WO1994002597A1 (en) 1992-07-23 1994-02-03 Novo Nordisk A/S MUTANT α-AMYLASE, DETERGENT, DISH WASHING AGENT, AND LIQUEFACTION AGENT
ATE262035T1 (de) 1992-10-06 2004-04-15 Novozymes As Zellulosevarianten
EP0692029B1 (de) * 1992-12-04 2007-05-09 Me Medical Enzymes Ag Gentechnologisch hergestellte glutaminase und ihre verwendung in therapie
PT867504E (pt) 1993-02-11 2003-08-29 Genencor Int Alfa-amilase estavel a oxidacao
KR950702240A (ko) 1993-04-27 1995-06-19 한스 발터 라벤 세제로의 이용을 위한 새로운 리파제 변형체
DK52393D0 (de) 1993-05-05 1993-05-05 Novo Nordisk As
JP2859520B2 (ja) 1993-08-30 1999-02-17 ノボ ノルディスク アクティーゼルスカブ リパーゼ及びそれを生産する微生物及びリパーゼ製造方法及びリパーゼ含有洗剤組成物
US6436690B1 (en) * 1993-09-15 2002-08-20 The Procter & Gamble Company BPN′ variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US5817495A (en) 1993-10-13 1998-10-06 Novo Nordisk A/S H2 O2 -stable peroxidase variants
JPH07143883A (ja) 1993-11-24 1995-06-06 Showa Denko Kk リパーゼ遺伝子及び変異体リパーゼ
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
DE69527835T2 (de) 1994-02-22 2003-04-10 Novozymes A/S, Bagsvaerd Methode zur herstellung einer variante eines lipolytischen enzymes
DE69536145D1 (de) 1994-03-08 2011-04-07 Novozymes As Neuartige alkalische Zellulasen
ZA952220B (en) * 1994-05-02 1995-12-14 Procter & Gamble Bpn' variants having decreased adsorption and increased hydrolysis wherein one or more loop regions are substituted
US6599730B1 (en) 1994-05-02 2003-07-29 Procter & Gamble Company Subtilisin 309 variants having decreased adsorption and increased hydrolysis
WO1995030744A2 (en) 1994-05-04 1995-11-16 Genencor International Inc. Lipases with improved surfactant resistance
WO1995035381A1 (en) 1994-06-20 1995-12-28 Unilever N.V. Modified pseudomonas lipases and their use
AU2884695A (en) 1994-06-23 1996-01-19 Unilever Plc Modified pseudomonas lipases and their use
DE69535733T2 (de) 1994-10-06 2009-04-23 Novozymes A/S Ein enzympräparat mit endoglucanase aktivität
BE1008998A3 (fr) 1994-10-14 1996-10-01 Solvay Lipase, microorganisme la produisant, procede de preparation de cette lipase et utilisations de celle-ci.
US5827719A (en) 1994-10-26 1998-10-27 Novo Nordisk A/S Enzyme with lipolytic activity
AR000862A1 (es) 1995-02-03 1997-08-06 Novozymes As Variantes de una ó-amilasa madre, un metodo para producir la misma, una estructura de adn y un vector de expresion, una celula transformada por dichaestructura de adn y vector, un aditivo para detergente, composicion detergente, una composicion para lavado de ropa y una composicion para la eliminacion del
JPH08228778A (ja) 1995-02-27 1996-09-10 Showa Denko Kk 新規なリパーゼ遺伝子及びそれを用いたリパーゼの製造方法
US5837516A (en) * 1995-03-03 1998-11-17 Genentech, Inc. Subtilisin variants capable of cleaving substrates containing basic residues
CN102080070B (zh) 1995-03-17 2016-01-20 诺沃奇梅兹有限公司 新的内切葡聚糖酶
ATE429490T1 (de) 1995-05-05 2009-05-15 Novozymes As Protease-varianten und verbindungen
EP0839186B1 (de) 1995-07-14 2004-11-10 Novozymes A/S Modifiziertes enzym mit lipolytischer aktivität
AU6655196A (en) 1995-08-11 1997-03-12 Novo Nordisk A/S Novel lipolytic enzymes
US5763385A (en) 1996-05-14 1998-06-09 Genencor International, Inc. Modified α-amylases having altered calcium binding properties
AU3938997A (en) 1996-08-26 1998-03-19 Novo Nordisk A/S A novel endoglucanase
EP1726644A1 (de) 1996-09-17 2006-11-29 Novozymes A/S Zellulase Varianten
WO1998015257A1 (en) 1996-10-08 1998-04-16 Novo Nordisk A/S Diaminobenzoic acid derivatives as dye precursors
JP4044143B2 (ja) 1996-11-04 2008-02-06 ノボザイムス アクティーゼルスカブ ズブチラーゼ変異体及び組成物
EP0932667B1 (de) 1996-11-04 2008-10-01 Novozymes A/S Subtilase varianten und verbindungen
WO1998034946A1 (en) 1997-02-12 1998-08-13 Massachusetts Institute Of Technology Daxx, a novel fas-binding protein that activates jnk and apoptosis
EP0913458B1 (de) * 1997-10-22 2004-06-16 The Procter & Gamble Company Flüssige Reinigungszusammensetzungen für harte Oberflächen
AR015977A1 (es) * 1997-10-23 2001-05-30 Genencor Int Variantes de proteasa multiplemente substituida con carga neta alterada para su empleo en detergentes
EP1032655B1 (de) 1997-11-21 2005-06-29 Novozymes A/S Protease-varianten und zusammensetzungen
AU1223000A (en) * 1998-10-23 2000-05-15 Procter & Gamble Company, The Methods for screening protease variants for use in detergent compositions
ATE355355T1 (de) * 1998-12-18 2006-03-15 Novozymes As Subtilasen der i-s1 und i-s2 untergruppen mit einem zusätzlichen aminosäurerest in der aktiven seitenschleifenregion
ATE342965T1 (de) * 1998-12-18 2006-11-15 Novozymes As Subtilase enzyme der i-s1 und is2 untergruppen, mit einem zusätzlichen aminosaürerest in einer aktiven schleifenregion
AU2200100A (en) * 1998-12-21 2000-07-12 Genencor International, Inc. Chemically modified enzymes with multiple charged variants
ATE402996T1 (de) 1999-05-20 2008-08-15 Novozymes As Subtilase-enzyme der i-s1 und i-s2 untergruppen mit wenigstens einem zusätzlichen aminosäurerest zwischen positionen 125 und 126
JP5563180B2 (ja) * 1999-05-20 2014-07-30 ノボザイムス アクティーゼルスカブ ９７位と９８位との間に少なくとも１個の追加のアミノ酸残基を有するｉ−ｓ１及びｉ−ｓ２サブグループのズブチラーゼ酵素
EP1244779B1 (de) * 1999-12-15 2014-05-07 Novozymes A/S Subtilasevarianten mit verbesserter waschleistung bei eierflecken
US6541234B1 (en) * 2000-09-11 2003-04-01 University Of Maryland Biotechnology Institute Calcium free subtilisin mutants
ATE505537T1 (de) * 2000-10-13 2011-04-15 Novozymes As Subtilase varianten
AU2002223020B2 (en) 2000-11-27 2006-07-06 Novozymes A/S Automated mechanical stress assay for screening cleaning ingredients
DK200101090A (da) * 2001-07-12 2001-08-16 Novozymes As Subtilase variants
TWI319007B (en) * 2002-11-06 2010-01-01 Novozymes As Subtilase variants

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2004041979A2 *

Also Published As

Publication number Publication date
BR0315916A (pt) 2005-09-20
TWI319007B (en) 2010-01-01
EP2138574B1 (de) 2019-06-19
CN103397010A (zh) 2013-11-20
AU2003277836B2 (en) 2009-01-29
AR077318A2 (es) 2011-08-17
KR20050072467A (ko) 2005-07-11
JP4694964B2 (ja) 2011-06-08
JP5474734B2 (ja) 2014-04-16
EP2138574A2 (de) 2009-12-30
KR101394294B1 (ko) 2014-05-13
CL2010000493A1 (es) 2010-10-08
CN103397010B (zh) 2016-08-10
KR20140021051A (ko) 2014-02-19
MXPA05004755A (es) 2005-08-02
EP2284258A3 (de) 2011-11-30
JP2013153763A (ja) 2013-08-15
JP5806255B2 (ja) 2015-11-10
EP2399992A3 (de) 2013-07-24
AR041993A1 (es) 2005-06-08
TW200418985A (en) 2004-10-01
KR20170037684A (ko) 2017-04-04
KR20120044360A (ko) 2012-05-07
EP2284258A2 (de) 2011-02-16
MY140915A (en) 2010-01-29
JP2011050392A (ja) 2011-03-17
CN105018451A (zh) 2015-11-04
WO2004041979A3 (en) 2004-09-10
EP2138574A3 (de) 2010-08-11
CA2503965A1 (en) 2004-05-21
CN101899428B (zh) 2015-08-05
JP2006505285A (ja) 2006-02-16
WO2004041979A2 (en) 2004-05-21
CA2503965C (en) 2013-10-08
EP2399992A2 (de) 2011-12-28
CN101899428A (zh) 2010-12-01
AU2003277836A1 (en) 2004-06-07
KR101293498B1 (ko) 2013-08-13

Similar Documents

Publication Publication Date Title
US9732310B2 (en) Subtilase variants
EP2138574B1 (de) Subtilase Varianten
EP2385112B1 (de) Subtilasevarianten
US9133423B2 (en) Subtilase variants
EP1326966B1 (de) Subtilase varianten
EP1183335A1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 130 und 131
EP1183339A1 (de) Subtilase enzyme der i-s1 und i-s2 untergruppen mit mindestens einer zusätzlichen aminosäure zwischen position 129 und 130

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050606

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20060704

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20150807

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151218